115 related articles for article (PubMed ID: 31576529)
21. Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells.
Montealegre-Sánchez L; Gimenes SNC; Lopes DS; Teixeira SC; Solano-Redondo L; de Melo Rodrigues V; Jiménez-Charris E
Curr Top Med Chem; 2019; 19(22):2069-2078. PubMed ID: 31385773
[TBL] [Abstract][Full Text] [Related]
22. [Potential use of snake venom components in cancer treatment].
Vivas D; Inga R; Yarlequé A
Rev Peru Med Exp Salud Publica; 2012; 29(3):396-401. PubMed ID: 23085804
[TBL] [Abstract][Full Text] [Related]
23. Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom.
Zhou Q; Hu P; Ritter MR; Swenson SD; Argounova S; Epstein AL; Markland FS
Arch Biochem Biophys; 2000 Mar; 375(2):278-88. PubMed ID: 10700384
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of pancreatic tumoral cells by snake venom disintegrins.
Lucena S; Castro R; Lundin C; Hofstetter A; Alaniz A; Suntravat M; Sánchez EE
Toxicon; 2015 Jan; 93():136-43. PubMed ID: 25450798
[TBL] [Abstract][Full Text] [Related]
25. Contortrostatin, a homodimeric disintegrin, binds to integrin alphavbeta5.
Zhou Q; Nakada MT; Brooks PC; Swenson SD; Ritter MR; Argounova S; Arnold C; Markland FS
Biochem Biophys Res Commun; 2000 Jan; 267(1):350-5. PubMed ID: 10623623
[TBL] [Abstract][Full Text] [Related]
26. Evolution of snake venom disintegrins by positive Darwinian selection.
Juárez P; Comas I; González-Candelas F; Calvete JJ
Mol Biol Evol; 2008 Nov; 25(11):2391-407. PubMed ID: 18701431
[TBL] [Abstract][Full Text] [Related]
27. Structural requirements of MLD-containing disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins.
Bazan-Socha S; Kisiel DG; Young B; Theakston RD; Calvete JJ; Sheppard D; Marcinkiewicz C
Biochemistry; 2004 Feb; 43(6):1639-47. PubMed ID: 14769041
[TBL] [Abstract][Full Text] [Related]
28. Saxatilin, a snake venom disintegrin, suppresses TNF-alpha-induced ovarian cancer cell invasion.
Kim DS; Jang YJ; Jeon OH; Kim DS
J Biochem Mol Biol; 2007 Mar; 40(2):290-4. PubMed ID: 17394781
[TBL] [Abstract][Full Text] [Related]
29. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
Mercer B; Markland F; Minkin C
J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
[TBL] [Abstract][Full Text] [Related]
30. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
[TBL] [Abstract][Full Text] [Related]
31. [Snake venom disintegrins: classification and therapeutic potential].
Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
[TBL] [Abstract][Full Text] [Related]
32. ADAM-Integrin Interactions: potential integrin regulated ectodomain shedding activity.
Bridges LC; Bowditch RD
Curr Pharm Des; 2005; 11(7):837-47. PubMed ID: 15777238
[TBL] [Abstract][Full Text] [Related]
33. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
Montenegro CF; Salla-Pontes CL; Ribeiro JU; Machado AZ; Ramos RF; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2012 Aug; 94(8):1812-20. PubMed ID: 22561350
[TBL] [Abstract][Full Text] [Related]
34. (99m)Tc-HisoDGR as a Potential SPECT Probe for Orthotopic Glioma Detection via Targeting of Integrin α5β1.
Zhao H; Gao H; Zhai L; Liu X; Jia B; Shi J; Wang F
Bioconjug Chem; 2016 May; 27(5):1259-66. PubMed ID: 27098436
[TBL] [Abstract][Full Text] [Related]
35. Anti-invasive effect of contortrostatin, a snake venom disintegrin, and TNF-alpha on malignant glioma cells.
Schmitmeier S; Markland FS; Chen TC
Anticancer Res; 2000; 20(6B):4227-33. PubMed ID: 11205252
[TBL] [Abstract][Full Text] [Related]
36. The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo.
Lin E; Wang Q; Swenson S; Jadvar H; Groshen S; Ye W; Markland FS; Pinski J
Prostate; 2010 Sep; 70(12):1359-70. PubMed ID: 20623636
[TBL] [Abstract][Full Text] [Related]
37. The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma.
Martínez-Vélez N; Xipell E; Vera B; Acanda de la Rocha A; Zalacain M; Marrodán L; Gonzalez-Huarriz M; Toledo G; Cascallo M; Alemany R; Patiño A; Alonso MM
Clin Cancer Res; 2016 May; 22(9):2217-25. PubMed ID: 26603261
[TBL] [Abstract][Full Text] [Related]
38. Contortrostatin, a snake venom disintegrin, induces alphavbeta3-mediated tyrosine phosphorylation of CAS and FAK in tumor cells.
Ritter MR; Zhou Q; Markland FS
J Cell Biochem; 2000 Jul; 79(1):28-37. PubMed ID: 10906753
[TBL] [Abstract][Full Text] [Related]
39. NMR structure of bitistatin – a missing piece in the evolutionary pathway of snake venom disintegrins.
Carbajo RJ; Sanz L; Perez A; Calvete JJ
FEBS J; 2015 Jan; 282(2):341-60. PubMed ID: 25363287
[TBL] [Abstract][Full Text] [Related]
40. Functional characteristic of snake venom disintegrins: potential therapeutic implication.
Marcinkiewicz C
Curr Pharm Des; 2005; 11(7):815-27. PubMed ID: 15777236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
